Abacavir
The serum concentration of Abacavir can be decreased when it is combined with Aprotinin.
Abciximab
The therapeutic efficacy of Abciximab can be decreased when used in combination with Aprotinin.
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Aprotinin.
Advertisement
Acetyl salicylate
The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Aprotinin.
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Aprotinin.
Aloxiprin
The therapeutic efficacy of Aloxiprin can be decreased when used in combination with Aprotinin.
Advertisement
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Aprotinin.
Alteplase
The therapeutic efficacy of Alteplase can be decreased when used in combination with Aprotinin.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Aprotinin.
Advertisement
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Aprotinin.
Amineptin
The serum concentration of Amineptine can be increased when it is combined with Aprotinin.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Aprotinin.
Amitriptyline
The serum concentration of Amitriptyline can be increased when it is combined with Aprotinin.
Amoxapine
The serum concentration of Amoxapine can be increased when it is combined with Aprotinin.
Anagrelide
The therapeutic efficacy of Anagrelide can be decreased when used in combination with Aprotinin.
Ancrod
The therapeutic efficacy of Ancrod can be decreased when used in combination with Aprotinin.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Aprotinin.
Anistreplase
The therapeutic efficacy of Anistreplase can be decreased when used in combination with Aprotinin.
Antithrombin III
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Aprotinin.
Antithrombin III, Human
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Aprotinin.
Apixaban
The therapeutic efficacy of Apixaban can be decreased when used in combination with Aprotinin.
Ardeparin
The therapeutic efficacy of Ardeparin can be decreased when used in combination with Aprotinin.
Argatroban
The therapeutic efficacy of Argatroban can be decreased when used in combination with Aprotinin.
Argatroban Anhydrous
The therapeutic efficacy of Argatroban can be decreased when used in combination with Aprotinin.
Aspirin
The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Aprotinin.
Astaxanthin
The therapeutic efficacy of Astaxanthin can be decreased when used in combination with Aprotinin.
Bemiparin
The therapeutic efficacy of Bemiparin can be decreased when used in combination with Aprotinin.
Benazepril
Aprotinin may decrease the antihypertensive activities of Benazepril.
Bivalirudin
The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Aprotinin.
Boceprevir
The serum concentration of Aprotinin can be decreased when it is combined with Boceprevir.
Bromocriptine
The serum concentration of Bromocriptine can be increased when it is combined with Aprotinin.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Aprotinin.
Cangrelor
The therapeutic efficacy of Cangrelor can be decreased when used in combination with Aprotinin.
Captopril
Aprotinin may decrease the antihypertensive activities of Captopril.
Carbamazepine
The metabolism of Aprotinin can be increased when combined with Carbamazepine.
Chlorotrianisene
The serum concentration of Chlorotrianisene can be decreased when it is combined with Aprotinin.
Cilazapril
Aprotinin may decrease the antihypertensive activities of Cilazapril.
Cilostazol
The therapeutic efficacy of Cilostazol can be decreased when used in combination with Aprotinin.
Clarithromycin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Aprotinin.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Aprotinin.
Clopidogrel
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Aprotinin.
Cyclobenzaprine
The serum concentration of Cyclobenzaprine can be increased when it is combined with Aprotinin.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Aprotinin is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Aprotinin is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Aprotinin.
Dabigatran Etexilate
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Aprotinin.
Dalteparin
The therapeutic efficacy of Dalteparin can be decreased when used in combination with Aprotinin.
Danaparoid
The therapeutic efficacy of Danaparoid can be decreased when used in combination with Aprotinin.
Defibrotide
The therapeutic efficacy of Defibrotide can be decreased when used in combination with Aprotinin.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Aprotinin.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Aprotinin.
Desirudin
The therapeutic efficacy of Desirudin can be decreased when used in combination with Aprotinin.
Dicumarol
The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Aprotinin.
Dienestrol
The serum concentration of Dienestrol can be decreased when it is combined with Aprotinin.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Aprotinin.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Aprotinin.
Dihydroergotamine
The serum concentration of Dihydroergotamine can be increased when it is combined with Aprotinin.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Aprotinin.
Dipyridamole
The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Aprotinin.
Dothiepin
The serum concentration of Dosulepin can be increased when it is combined with Aprotinin.
Doxepin
The serum concentration of Doxepin can be increased when it is combined with Aprotinin.
Drotrecogin Alfa
The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Aprotinin.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Aprotinin.
Enalapril
Aprotinin may decrease the antihypertensive activities of Enalapril.
Enalaprilat
Aprotinin may decrease the antihypertensive activities of Enalaprilat.
Enalaprilat Anhydrous
Aprotinin may decrease the antihypertensive activities of Enalaprilat.
Enfuvirtide
The serum concentration of Enfuvirtide can be increased when it is combined with Aprotinin.
Enoxaparin
The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Aprotinin.
Enoxaparin sodium
The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Aprotinin.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Aprotinin.
Eptifibatide
The therapeutic efficacy of Eptifibatide can be decreased when used in combination with Aprotinin.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Aprotinin.
Ergonovine
The serum concentration of Ergonovine can be increased when it is combined with Aprotinin.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Aprotinin.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Aprotinin.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Aprotinin.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Aprotinin.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Aprotinin.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Aprotinin.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Aprotinin.
Fibrinogen
The risk or severity of adverse effects can be increased when Aprotinin is combined with Fibrinogen Human.
Fibrinogen Concentrate (human)
The risk or severity of adverse effects can be increased when Aprotinin is combined with Fibrinogen Human.
Fluindione
The therapeutic efficacy of Fluindione can be decreased when used in combination with Aprotinin.
Fondaparinux
The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Aprotinin.
Fosinopril
Aprotinin may decrease the antihypertensive activities of Fosinopril.
Garlic Allergenic Extract
The serum concentration of Aprotinin can be decreased when it is combined with Garlic.
Heparin
The therapeutic efficacy of Heparin can be decreased when used in combination with Aprotinin.
Hypoxis hemerocallidea root extract
The metabolism of Aprotinin can be increased when combined with St. John's Wort.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Aprotinin.
Imidapril
Aprotinin may decrease the antihypertensive activities of Imidapril.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Aprotinin.
Indobufen
The therapeutic efficacy of Indobufen can be decreased when used in combination with Aprotinin.
Lepirudin
The therapeutic efficacy of Lepirudin can be decreased when used in combination with Aprotinin.
Lisinopril
Aprotinin may decrease the antihypertensive activities of Lisinopril.
Lisinopril Anhydrous
Aprotinin may decrease the antihypertensive activities of Lisinopril.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Aprotinin.
Meperidine
The risk or severity of adverse effects can be increased when Aprotinin is combined with Pethidine.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Aprotinin.
Methylergonovine
The serum concentration of Methylergometrine can be increased when it is combined with Aprotinin.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Aprotinin.
Mirtazapine
The serum concentration of Mirtazapine can be increased when it is combined with Aprotinin.
Moexipril
Aprotinin may decrease the antihypertensive activities of Moexipril.
Nadroparin
The therapeutic efficacy of Nadroparin can be decreased when used in combination with Aprotinin.
Nefazodone
The serum concentration of Nefazodone can be increased when it is combined with Aprotinin.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Aprotinin.
Opipramol
The serum concentration of Opipramol can be increased when it is combined with Aprotinin.
Parnaparin
The therapeutic efficacy of Parnaparin can be decreased when used in combination with Aprotinin.
Pentaerythritol Tetranitrate
The therapeutic efficacy of Pentaerythritol Tetranitrate can be decreased when used in combination with Aprotinin.
Perindopril
Aprotinin may decrease the antihypertensive activities of Perindopril.
Phenindione
The therapeutic efficacy of Phenindione can be decreased when used in combination with Aprotinin.
Phenprocoumon
The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Aprotinin.
Plasmin
The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Aprotinin.
Prasugrel
The therapeutic efficacy of Prasugrel can be decreased when used in combination with Aprotinin.
protein C, human
The therapeutic efficacy of Protein C can be decreased when used in combination with Aprotinin.
Protriptyline
The serum concentration of Protriptyline can be increased when it is combined with Aprotinin.
Quinapril
Aprotinin may decrease the antihypertensive activities of Quinapril.
Ramipril
Aprotinin may decrease the antihypertensive activities of Ramipril.
Rescinnamine
Aprotinin may decrease the antihypertensive activities of Rescinnamine.
Reteplase
The therapeutic efficacy of Reteplase can be decreased when used in combination with Aprotinin.
Reviparin
The therapeutic efficacy of Reviparin can be decreased when used in combination with Aprotinin.
Reviparin sodium
The therapeutic efficacy of Reviparin can be decreased when used in combination with Aprotinin.
Riociguat
The serum concentration of Riociguat can be increased when it is combined with Aprotinin.
Rivaroxaban
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Aprotinin.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Aprotinin.
Selexipag
The therapeutic efficacy of Selexipag can be decreased when used in combination with Aprotinin.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Aprotinin.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Aprotinin.
Spirapril
Aprotinin may decrease the antihypertensive activities of Spirapril.
ST. JOHN'S WORT EXTRACT
The metabolism of Aprotinin can be increased when combined with St. John's Wort.
Streptokinase
The therapeutic efficacy of Streptokinase can be decreased when used in combination with Aprotinin.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Aprotinin.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Aprotinin.
Temsirolimus
The risk or severity of adverse effects can be increased when Aprotinin is combined with Temsirolimus.
Tenecteplase
The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Aprotinin.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Aprotinin.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Aprotinin.
Tianeptine
The serum concentration of Tianeptine can be increased when it is combined with Aprotinin.
Ticagrelor
The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Aprotinin.
Ticlopidine
The therapeutic efficacy of Ticlopidine can be decreased when used in combination with Aprotinin.
Tinzaparin
The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Aprotinin.
Tinzaparin sodium
The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Aprotinin.
Tipranavir
The serum concentration of Aprotinin can be decreased when it is combined with Tipranavir.
Tirofiban
The therapeutic efficacy of Tirofiban can be decreased when used in combination with Aprotinin.
Trandolapril
Aprotinin may decrease the antihypertensive activities of Trandolapril.
Treprostinil
The therapeutic efficacy of Treprostinil can be decreased when used in combination with Aprotinin.
Tretinoin
Tretinoin may increase the thrombogenic activities of Aprotinin.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Aprotinin.
Triflusal
The therapeutic efficacy of Triflusal can be decreased when used in combination with Aprotinin.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Aprotinin.
Urokinase
The therapeutic efficacy of Urokinase can be decreased when used in combination with Aprotinin.
Valproate
The serum concentration of Valproic Acid can be decreased when it is combined with Aprotinin.
Valproic Acid
The serum concentration of Valproic Acid can be decreased when it is combined with Aprotinin.
Verapamil
The metabolism of Verapamil can be decreased when combined with Aprotinin.
Vorapaxar
The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Aprotinin.
Warfarin
The therapeutic efficacy of Warfarin can be decreased when used in combination with Aprotinin.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Aprotinin.
Zofenopril
Aprotinin may decrease the antihypertensive activities of Zofenopril.
